KR940008690A - 에리트로포이에틴 항빈혈작용 증강제 - Google Patents

에리트로포이에틴 항빈혈작용 증강제 Download PDF

Info

Publication number
KR940008690A
KR940008690A KR1019930022562A KR930022562A KR940008690A KR 940008690 A KR940008690 A KR 940008690A KR 1019930022562 A KR1019930022562 A KR 1019930022562A KR 930022562 A KR930022562 A KR 930022562A KR 940008690 A KR940008690 A KR 940008690A
Authority
KR
South Korea
Prior art keywords
spherical
erythropoietin
anemia
enhancers
charcoal
Prior art date
Application number
KR1019930022562A
Other languages
English (en)
Other versions
KR970002609B1 (ko
Inventor
미찌히또 이세
에이오 히야시
Original Assignee
고다마 슌이찌로
구레하 가가꾸 고교 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 고다마 슌이찌로, 구레하 가가꾸 고교 가부시끼가이샤 filed Critical 고다마 슌이찌로
Publication of KR940008690A publication Critical patent/KR940008690A/ko
Application granted granted Critical
Publication of KR970002609B1 publication Critical patent/KR970002609B1/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/44Elemental carbon, e.g. charcoal, carbon black
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1816Erythropoietin [EPO]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

본 발명은 구형탄(예를 들면, 구형 활성탄 또는 구형 흡착탄)을 유효 성분으로 하는 에리트로포이에틴 항빈혈작용의 증강제에 관한 것이다. 구형탄의 병용에 의해 에리트로포이에틴의 항빈혈작용이 현저히 증가되고 에리트로포이에틴에 관한 부작용은 현저히 경감된다.

Description

에리트로포이에틴 항빈혈작용 증강제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (3)

  1. 구형탄을 유효 성분으로하는 에리트로포에틴 항빈작용 증강제.
  2. 제1항에 있어서, 구형탄이 구형 활성탄인 증강제.
  3. 제1항에 있어서, 구형탄이 구형 흡착탄인 증강제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019930022562A 1992-10-29 1993-10-28 에리트로포이에틴 항빈혈작용 증강제 KR970002609B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP31418192 1992-10-29
JP92-314181 1992-10-29

Publications (2)

Publication Number Publication Date
KR940008690A true KR940008690A (ko) 1994-05-16
KR970002609B1 KR970002609B1 (ko) 1997-03-06

Family

ID=18050237

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930022562A KR970002609B1 (ko) 1992-10-29 1993-10-28 에리트로포이에틴 항빈혈작용 증강제

Country Status (8)

Country Link
US (1) US5399551A (ko)
EP (1) EP0595716A1 (ko)
KR (1) KR970002609B1 (ko)
CN (1) CN1090175A (ko)
AU (1) AU657439B2 (ko)
CA (1) CA2108330C (ko)
PH (1) PH30280A (ko)
TW (1) TW270086B (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830851A (en) * 1993-11-19 1998-11-03 Affymax Technologies N.V. Methods of administering peptides that bind to the erythropoietin receptor
US5773569A (en) * 1993-11-19 1998-06-30 Affymax Technologies N.V. Compounds and peptides that bind to the erythropoietin receptor
US5951996A (en) * 1998-02-04 1999-09-14 Czeizler Zaharia; Veronica L. Treatment of chronic diffuse GI bleeding with erythropoietin
US6703480B1 (en) * 1999-11-24 2004-03-09 Palani Balu Peptide dimers as agonists of the erythropoientin (EPO) receptor, and associated methods of synthesis and use
US6956023B1 (en) 2001-04-19 2005-10-18 University Of Florida Materials and methods for providing nutrition to neonates
US6833351B2 (en) 2001-05-21 2004-12-21 Douglas T. Dieterich Method of treating anemia caused by ribavirin treatment of hepatitis C using erythropoietin alpha
CN1615908B (zh) * 2003-10-22 2011-09-28 株式会社吴羽 口服给药用吸附剂、以及肾病治疗或预防剂、和肝病治疗或预防剂
US20070207917A1 (en) * 2006-02-14 2007-09-06 Chester Wayne Sink Activated carbon monoliths and methods of making them
US8247072B2 (en) * 2006-02-14 2012-08-21 Eastman Chemical Company Resol beads, methods of making them and methods of using them
US20070191571A1 (en) * 2006-02-14 2007-08-16 Sink Chester W Resol beads, methods of making them, and methods of using them
US20070191572A1 (en) * 2006-02-14 2007-08-16 Tustin Gerald C Resol beads, methods of making them, and methods of using them

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5673542A (en) * 1979-11-22 1981-06-18 Kureha Chem Ind Co Ltd Adsorbent
JPS57189669A (en) * 1981-05-19 1982-11-22 Toushiyou Bussan Kk Spirillum composition
JPS6197229A (ja) * 1984-10-18 1986-05-15 Chugai Pharmaceut Co Ltd 安定なエリトロポエチン製剤
JPH0549694A (ja) * 1991-08-28 1993-03-02 Asahi Medical Co Ltd 造影剤の吸着体

Also Published As

Publication number Publication date
CA2108330C (en) 1998-12-08
EP0595716A1 (en) 1994-05-04
PH30280A (en) 1997-02-20
AU4915393A (en) 1994-05-12
US5399551A (en) 1995-03-21
KR970002609B1 (ko) 1997-03-06
CA2108330A1 (en) 1994-04-30
AU657439B2 (en) 1995-03-09
CN1090175A (zh) 1994-08-03
TW270086B (ko) 1996-02-11

Similar Documents

Publication Publication Date Title
KR950005319A (ko) 약학적 조성물
KR910004173A (ko) 치조농루 예방껌
KR840008264A (ko) 살서제 조성물
KR940008689A (ko) 항네프로제증후군제
KR940008690A (ko) 에리트로포이에틴 항빈혈작용 증강제
KR910009279A (ko) 세포 보호제 조성물
KR890011588A (ko) 간 섬유증 억제제
KR900004215A (ko) Hdtv-텔레비젼 수신기용 스피커장치
KR890009263A (ko) 의류용 방충 에어졸제
KR930016096A (ko) 상처 치유 촉진용 조성물
KR910000106A (ko) 발모촉진제
KR900001298A (ko) 제초성 입상 조성물
KR910000115A (ko) 멜라닌 생성 억제 외용제
KR940006465A (ko) 주사제용 보존제
KR890011527A (ko) 살균성4,5-디클로로-1,2-디티올-3-온 조성물
KR910001098A (ko) 닭털 및 오리털의 원단화
KR920001435A (ko) 헤드베이스
KR870003785A (ko) 급성 위염치료제
KR830001645A (ko) 항종양제
KR920021637A (ko) 방수 시이트 조성물
KR880005336A (ko)
KR920012417A (ko) 축산공해방지용(畜産公害防止用) 활성발효제(活性醱酵劑)의 조성방법(造成方法)
KR890003308A (ko) 쑥을 사용한 흡연초 쑥권연
KR890002390A (ko) 과산화효소 및 과산화효소 관련 제품의 보존제로서 시클로피록솔아민의 용도
KR910019591A (ko) 발모제 조성물

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20000229

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee